Dr Ricardo Petraco, Consultant Cardiologist

Dr Ricardo Petraco

Consultant Cardiologist

Book online
|

Dr Ricardo Petraco MD PhD MRCP

Consultant Cardiologist

MD PhD MRCP

Dr Ricardo Petraco

Consultant Cardiologist MD PhD MRCP

Book online
|
MD PhD MRCP

Areas of expertise

  • Angina
  • Breathlessness
  • Chest pain
  • Coronary artery disease
  • Heart failure

Address

About Dr Ricardo Petraco

GMC number: 6138782

Year qualified: 2002

Place of primary qualification: Fundacao Faculdade Federal de Ciencas Medicas de Porto Alegre

Dr Petraco is an internationally recognised cardiologist specialising in coronary artery disease. With extensive clinical and academic experience, Dr Petraco focuses on the diagnosis and treatment of cardiac chest pain, also known as angina, and heart attacks. He has a particular expertise in coronary physiology and intravascular imaging.

Dr Petraco's medical journey began in Brazil, followed by an advanced 12-year cardiology training at leading London teaching hospitals, including St Mary's, Royal Brompton, and Hammersmith Hospitals. He specialises in coronary interventional procedures, such as coronary angiograms and stenting. Since his appointment in 2012, he has been a key figure at Mayo Clinic Healthcare, providing state-of-the-art cardiac diagnosis and treatment options.

As an interventionalist, Dr Petraco is known for his innovative approaches and diagnostic developments in coronary procedures. He performs a range of procedures, including cardiovascular risk screening, coronary calcium scoring, CT scans, dobutamine stress echocardiography, ECG monitoring, MRI, and stress exercise testing. His areas of expertise include treating conditions such as angina, breathlessness, chest pain, coronary artery disease, and heart failure.

Dr Petraco's dedication to education is evident in his role as an international proctor and educator on coronary physiology and imaging. He teaches colleagues and cardiac catheterisation lab teams worldwide on best practices for using novel diagnostic modalities. In addition, he earned his PhD from Imperial College London, where he supervises PhD students and remains an active researcher in coronary physiology and imaging.

Dr Petraco has published over 100 peer-reviewed articles and has written several chapters for textbooks and practice manuals. His current research focuses on developing novel methods based on artificial intelligence to aid decision-making during cardiac procedures. He is fluent in English and Portuguese and comprehends Spanish.

Areas of expertise

  • Acute coronary syndrome (ACS)
  • Angina
  • Arrhythmia (irregular heartbeat)
  • Atherosclerosis
  • Atrial fibrillation
  • Atrial septal defects (ASD)
  • Blood pressure monitoring
  • Bradycardia
  • Bubble contrast echocardiography
  • Cardiac MRI
  • Cardio-pulmonary exercise testing
  • Cardiomyopathy
  • Cardiovascular disease
  • Cardioversion
  • Chest pain
  • Congestive heart failure
  • Coronary angiography
  • Coronary artery disease
  • CT coronary angiogram
  • Dizziness
  • ECG monitor
  • Echocardiogram
  • Electrocardiogram (ECG)
  • Exercise stress test
  • Heart failure
  • Heart murmurs
  • Heart muscle disease
  • Heart valve problems
  • High blood pressure
  • Loss of consciousness (syncope)
  • Neurocardiogenic syncope (vasovagal)
  • Palpitations
  • Patent foramen ovale (PFO) closure
  • Tachycardia
  • Transcatheter aortic valve implantation (TAVI)
  • Valvular heart disease
  • Valvuloplasty

Professional memberships

General Medical Council
Royal College of Physicians

Articles by Dr Ricardo Petraco

Cardiopulmonary exercise testing and efficacy of percutaneous coronary intervention: a substudy of the ORBITA trial.

Hyponatraemia: A strong predictor of mortality in adults with congenital heart disease.

Development and validation of a new adenosine-independent index of stenosis severity from coronary wave-intensity analysis: results of the ADVISE (ADenosine Vasodilator Independent Stenosis Evaluation) study.

Classification performance of instantaneous wave-free ratio (iFR) and fractional flow reserve in a clinical population of intermediate coronary stenoses: results of the ADVISE registry.

First-in-man safety evaluation of renal denervation for chronic systolic heart failure: primary outcome from REACH-Pilot study.

Maximal expansion capacity with current DES platforms: a critical factor for stent selection in the treatment of left main bifurcations?

Importance of knowing stent design threshold diameters and post-dilatation capacities to optimise stent selection and prevent stent overexpansion/incomplete apposition during PCI.

Hybrid iFR-FFR decision-making strategy: implications for enhancing universal adoption of physiology-guided coronary revascularisation.